ArticleBMC cardiovascular disorders2026
Association between normal-weight central obesity and cardiometabolic disorders: a longitudinal analysis from health check-up data.
Article in BMC cardiovascular disorders, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
backgroundAlthough several cross-sectional studies have examined the relationship between normal-weight central obesity (NWCO) and the risk of cardiometabolic disorders (CMD), longitudinal evidence from cohort studies is still limited, especially regarding diverse CMD outcomes in Chinese populations.
methodsWe conducted a retrospective cohort study by using health examination records from Jiangsu Province Geriatric Hospital. The study included 5,606 normal-weight (body mass index of 18.0-24.0 kg/m
resultsAmong all participants (median age 40 years), 388 (6.9%) had NWCO. During a mean follow-up of 1.98[Formula: see text]0.18 years, NWCO was associated with a greater risk for CMD (HR: 1.39, 95% CI: 1.13-1.71) compared with NWNO group. Similar risk elevations were observed for CMD components, including hypertension (HTN), diabetes mellitus (DM) and hyperlipidemia (HLP).
conclusionOur analysis of a longitudinal health check-up database demonstrated the potential impact of NWCO on the risk for CMD, confirming the importance of abdominal obesity in the development of CMD even in normal-weight individuals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.